| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 21 | 28 | 35 | 36 | |
Growth YoY Revenue Growth YoY% | 65.0 | 25.9 | ||
| 19 | 25 | 31 | 32 | |
| 2 | 3 | 4 | 4 | |
OPM OPM% | 10.8 | 11.6 | 11.4 | 11.9 |
| 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 3 | 4 | 4 |
| 1 | 1 | 1 | 1 | |
| 2 | 2 | 3 | 3 | |
Growth YoY PAT Growth YoY% | 75.7 | 22.4 | ||
NPM NPM% | 8.0 | 8.7 | 8.5 | 8.4 |
| 0.0 | 0.0 | 2.6 | 2.1 |
| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 21 | 28 | 35 | 36 | |
Growth YoY Revenue Growth YoY% | 65.0 | 25.9 | ||
| 19 | 25 | 31 | 32 | |
| 2 | 3 | 4 | 4 | |
OPM OPM% | 10.8 | 11.6 | 11.4 | 11.9 |
| 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 3 | 4 | 4 |
| 1 | 1 | 1 | 1 | |
| 2 | 2 | 3 | 3 | |
Growth YoY PAT Growth YoY% | 75.7 | 22.4 | ||
NPM NPM% | 8.0 | 8.7 | 8.5 | 8.4 |
| 0.0 | 0.0 | 2.6 | 2.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 8 | 7 | 32 | 50 | 71 |
Growth Revenue Growth% | -2.1 | 323.8 | 57.1 | 42.6 | |
| 7 | 7 | 28 | 44 | 63 | |
| 0 | 1 | 4 | 6 | 8 | |
OPM OPM% | 4.6 | 7.9 | 12.5 | 11.3 | 11.6 |
| 0 | 0 | 0 | |||
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 0 | 1 | 4 | 6 | 8 |
| 0 | 0 | 1 | 1 | 2 | |
PAT PATCr | 0 | 0 | 3 | 4 | 6 |
Growth PAT Growth% | 115.8 | 610.6 | 42.2 | 44.4 | |
NPM NPM% | 2.5 | 5.5 | 9.2 | 8.3 | 8.4 |
| 20.0 | 4.0 | 4.7 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 8 | 7 | 32 | 50 | 71 |
Growth Revenue Growth% | -2.1 | 323.8 | 57.1 | 42.6 | |
| 7 | 7 | 28 | 44 | 63 | |
| 0 | 1 | 4 | 6 | 8 | |
OPM OPM% | 4.6 | 7.9 | 12.5 | 11.3 | 11.6 |
| 0 | 0 | 0 | |||
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 0 | 1 | 4 | 6 | 8 |
| 0 | 0 | 1 | 1 | 2 | |
PAT PATCr | 0 | 0 | 3 | 4 | 6 |
Growth PAT Growth% | 115.8 | 610.6 | 42.2 | 44.4 | |
NPM NPM% | 2.5 | 5.5 | 9.2 | 8.3 | 8.4 |
| 20.0 | 4.0 | 4.7 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 5 | 10 | 14 |
Reserves ReservesCr | 7 | 7 | 24 |
| 3 | 6 | 12 | |
| 0 | 0 | 0 | |
| 15 | 23 | 50 | |
| 15 | 23 | 50 | |
| 0 | 0 | 0 | |
| 15 | 23 | 50 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 5 | 10 | 14 |
Reserves ReservesCr | 7 | 7 | 24 |
| 3 | 6 | 12 | |
| 0 | 0 | 0 | |
| 15 | 23 | 50 | |
| 15 | 23 | 50 | |
| 0 | 0 | 0 | |
| 15 | 23 | 50 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 0 | 0 | -7 | 0 | -19 | |
| 0 | 0 | 0 | 0 | 0 | |
| 1 | 0 | 7 | 1 | 19 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | -1 |
Free Cash Flow Free Cash FlowCr | -7 | 0 | -19 | ||
CFO To PAT CFO To PAT% | -210.5 | 107.3 | -244.0 | 0.5 | -325.6 |
CFO To EBITDA CFO To EBITDA% | -114.3 | 74.6 | -179.7 | 0.4 | -236.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 0 | 0 | -7 | 0 | -19 | |
| 0 | 0 | 0 | 0 | 0 | |
| 1 | 0 | 7 | 1 | 19 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | -1 |
Free Cash Flow Free Cash FlowCr | -7 | 0 | -19 | ||
CFO To PAT CFO To PAT% | -210.5 | 107.3 | -244.0 | 0.5 | -325.6 |
CFO To EBITDA CFO To EBITDA% | -114.3 | 74.6 | -179.7 | 0.4 | -236.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 23 | 26 | ||||
Price To Earnings Price To Earnings | 3.9 | 3.9 | ||||
Price To Sales Price To Sales | 0.3 | 0.4 | ||||
Price To Book Price To Book | 0.6 | 0.7 | ||||
EV To EBITDA EV To EBITDA | 3.4 | 4.3 | ||||
GPM GPM% | 13.3 | 12.1 | 12.6 | 12.6 | ||
OPM OPM% | 4.6 | 7.9 | 12.5 | 11.3 | 11.6 | 11.6 |
NPM NPM% | 2.5 | 5.5 | 9.2 | 8.3 | 8.4 | 8.4 |
ROCE ROCE% | 32.8 | 30.9 | 19.2 | 19.2 | ||
ROE ROE% | 24.9 | 23.9 | 15.8 | 15.8 | ||
ROA ROA% | 19.5 | 18.0 | 11.9 | 11.9 | ||
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 23 | 26 | ||||
Price To Earnings Price To Earnings | 3.9 | 3.9 | ||||
Price To Sales Price To Sales | 0.3 | 0.4 | ||||
Price To Book Price To Book | 0.6 | 0.7 | ||||
EV To EBITDA EV To EBITDA | 3.4 | 4.3 | ||||
GPM GPM% | 13.3 | 12.1 | 12.6 | 12.6 | ||
OPM OPM% | 4.6 | 7.9 | 12.5 | 11.3 | 11.6 | 11.6 |
NPM NPM% | 2.5 | 5.5 | 9.2 | 8.3 | 8.4 | 8.4 |
ROCE ROCE% | 32.8 | 30.9 | 19.2 | 19.2 | ||
ROE ROE% | 24.9 | 23.9 | 15.8 | 15.8 | ||
ROA ROA% | 19.5 | 18.0 | 11.9 | 11.9 | ||
Documents — Medistep Healthcare Ltd